EVP Chief Commercial Officer of Dexcom Inc (30-Year Financial, Insider Trades) Richard Doubleday (insider trades) sold 1,530 shares of DXCM on 09/24/2020 at an average price of $380.95 a share. The total sale was $582,854.
DexCom Inc designs, develops and commercializes continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients. DexCom Inc has a market cap of $38.32 billion; its shares were traded at around $400.19 with a P/E ratio of 182.74 and P/S ratio of 21.93. GuruFocus has detected 3 severe warning signs with DexCom Inc. .
CEO Recent Trades:
- President, CEO and Chairman Kevin R Sayer sold 9,965 shares of DXCM stock on 09/09/2020 at the average price of $398.3. The price of the stock has increased by 0.47% since.
CFO Recent Trades:
- COO & CFO Quentin S. Blackford sold 25,079 shares of DXCM stock on 09/10/2020 at the average price of $399.41. The price of the stock has increased by 0.2% since.
Directors and Officers Recent Trades:
- EVP Strategy and Corporate Dev Steven Robert Pacelli sold 2,000 shares of DXCM stock on 09/25/2020 at the average price of $400.07. The price of the stock has increased by 0.03% since.
- EVP Chief Commercial Officer Richard Doubleday sold 1,530 shares of DXCM stock on 09/24/2020 at the average price of $380.95. The price of the stock has increased by 5.05% since.
- EVP Strategy and Corporate Dev Steven Robert Pacelli sold 1,079 shares of DXCM stock on 09/23/2020 at the average price of $395.11. The price of the stock has increased by 1.29% since.
- Director Nicholas Augustinos sold 1,875 shares of DXCM stock on 09/16/2020 at the average price of $399.78. The price of the stock has increased by 0.1% since.
- * Andrew K Balo sold 5,256 shares of DXCM stock on 09/15/2020 at the average price of $397.35. The price of the stock has increased by 0.71% since.
For the complete insider trading history of DXCM, click here
.
